• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry

Share:

July 15, 2021

Reportlinker.com announces the release of the report “Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry – Implications and Outlook – 2021 Edition” – https://www.reportlinker.com/p06103613/?utm_source=GNW

Scope

This 55-page report gives important, expert insight you won’t find in any other source. 28 tables and figures throughout the report illustrate major points and trends.

This report is required reading for –

– CMOS: market trends, strategic planning, competitive intelligence, performance benchmarking
– Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
– Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking

Reasons to Buy

– Overview of M&A in the Pharma CMO Industry
– Detailed view of CDMO performance by the number of deals completed from the Deals database
– Analysis of the M&A of specific manufacturing services

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Finance.Yahoo

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Arlington Capital Partners Announces the Sale of Avalign TechnologiesArlington Capital Partners Announces the Sale of Avalign Technologies
  • Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug CandidateOragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
  • Sanofi, Advent finally shake hands on $2.2B European generics saleSanofi, Advent finally shake hands on $2.2B European generics sale
  • Enable My Child Raises $1.2M in Seed FundingEnable My Child Raises $1.2M in Seed Funding
  • Greenphire Announces Strategic Growth Investment from Thoma BravoGreenphire Announces Strategic Growth Investment from Thoma Bravo
  • Cybin | Revolutionizing Mental Health with Innovative Psychedelic TherapiesCybin | Revolutionizing Mental Health with Innovative Psychedelic Therapies
  • SP Acquires Spain Based i-DositecnoSP Acquires Spain Based i-Dositecno
  • Integrity Implants and Fusion Robotics Merge to Form AccelusAccelus to Offer Procedure-Enabling Technology with the Goal of Making Minimally Invasive Surgery (MIS) the Standard of Care in SpineIntegrity Implants and Fusion Robotics Merge to Form AccelusAccelus to Offer Procedure-Enabling Technology with the Goal of Making Minimally Invasive Surgery (MIS) the Standard of Care in Spine

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications